Mirae Asset Global ETFs Holdings
MGNX icon

Mirae Asset Global ETFs Holdings’s MacroGenics MGNX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,539
Closed -$46.4K – 3149
2025
Q1 		$46.4K Buy
36,539
+1,560
+4% +$4.08K ﹤0.01% 2864
2024
Q4 		$114K Buy
34,979
+726
+2% +$2.62K ﹤0.01% 2654
2024
Q3 		$113K Buy
34,253
+3,340
+11% +$13K ﹤0.01% 2661
2024
Q2 		$131K Buy
+30,913
New +$301K ﹤0.01% 2454

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MGNX Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 36,539 shares — an estimated $46.4K sold.

Mirae Asset Global ETFs Holdings first reported a position in MGNX in Q2 2024 and held it in 4 quarters. The position peaked at $131K in Q2 2024. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 36,539 MacroGenics shares in Q2 2025, an estimated $46.4K.
  • Mirae Asset Global ETFs Holdings first reported a position in MacroGenics in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's MacroGenics position peaked at $131K in Q2 2024.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.